Juno Pharmaceuticals Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
371 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FOSAPREPITANT JUNO fosaprepitant (as dimeglumine) 150 mg powder for injection vial.
-
Prescription medicine registrationActive ingredients: cyclizine lactate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VANCOMYCIN JUNO vancomycin (as hydrochloride) 1 g powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VANCOMYCIN JUNO vancomycin (as hydrochloride) 500 mg powder for injection vial.
-
Australian Public Assessment Report (AusPAR)Exarane/Exarane Forte (enoxaparin sodium) has been approved for the prevention of thrombo-embolic disorders, thrombosis and prophylaxis of venous thromboembolism. It has also been approved for the treatment of deep vein thrombosis, unstable angina, non-Q-wave myocardial infarction and acute ST-segment elevation myocardial infarction.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE FORTE enoxaparin sodium 120mg/0.8mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 60mg/0.6mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 20mg/0.2mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE enoxaparin sodium 100mg/1mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EXARANE FORTE enoxaparin sodium 150mg/1mL solution for injection prefilled syringe.